In the UK, diagnostic germline genetic testing of the BRCA1/BRCA2 (hereafter BRCA1/2) genes is routinely offered through the National Health Service (NHS) to patients with a personal history (and in some cases a wider family history) of breast and/or epithelial ovarian cancer. The gene discussed is BRCA2; the disease is ovarian carcinoma.